Allied Corp. Cultivates UK Expansion with New Cannabis Deal
Kelowna, BC -- January 29, 2024 -- NewsGenie -- Allied Corp. (OTC:ALID) has secured a three-year sales and distribution agreement for the UK market, marking a significant step in its European expansion. This follows the expansion of Allied’s commercial team in 2023 and strategic partnerships aimed at distributing EU-GMP manufactured products across Europe.
The UK market is projected to become the second-largest medical cannabis market in Europe, trailing only Germany, according to Prohibition Partner’s 2023 European Cannabis Report. Juba Hadid, VP of Global Sales, highlighted the company's dedication to expanding its commercial efforts, calling the deal a significant milestone.
The agreement involves Allied, its EU-GMP manufacturing partner, and a licensed UK medical cannabis distributor. Allied will supply Colombian-grown medical cannabis through its partner for three years, with an option to renew. The agreement includes specified minimum monthly order quantities and a yearly volume commitment.
Allied Corp. is an international cannabis company with a production center in Colombia. Known for being among the first to export commercial cannabis flower from Colombia, Allied leverages Colombian advantages and Canadian cultivation expertise to ensure a consistent supply of premium cannabis products at competitive prices, while maintaining high-quality standards.